China Resources Medical Holdings Company Limited (1515.HK)
HKD 3.65
(-1.62%)
HKD 3.65
(-1.62%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 10.1 Billion CNY | 79.83% |
| 2022 | 5.62 Billion CNY | 26.37% |
| 2021 | 4.44 Billion CNY | 61.69% |
| 2020 | 2.75 Billion CNY | 30.03% |
| 2019 | 2.11 Billion CNY | 2.71% |
| 2018 | 2.05 Billion CNY | 9.68% |
| 2017 | 1.87 Billion CNY | 22.5% |
| 2016 | 1.53 Billion CNY | 11.7% |
| 2015 | 1.37 Billion CNY | 13.76% |
| 2014 | 1.2 Billion CNY | 35.94% |
| 2013 | 887.35 Million CNY | 17.06% |
| 2012 | 758.03 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.97 Billion CNY | 0.0% |
| 2023 Q2 | 5.11 Billion CNY | 0.0% |
| 2023 FY | 10.1 Billion CNY | 79.83% |
| 2023 Q4 | 4.99 Billion CNY | 0.0% |
| 2022 Q2 | 3.2 Billion CNY | 0.0% |
| 2022 FY | 5.62 Billion CNY | 26.37% |
| 2022 Q4 | 4.69 Billion CNY | 0.0% |
| 2021 Q2 | 1.77 Billion CNY | 0.0% |
| 2021 FY | 4.44 Billion CNY | 61.69% |
| 2021 Q4 | 2.67 Billion CNY | 0.0% |
| 2020 Q2 | 907.41 Million CNY | 0.0% |
| 2020 Q4 | 1.84 Billion CNY | 0.0% |
| 2020 FY | 2.75 Billion CNY | 30.03% |
| 2019 Q4 | 1.15 Billion CNY | 0.0% |
| 2019 FY | 2.11 Billion CNY | 2.71% |
| 2019 Q2 | 964.93 Million CNY | 0.0% |
| 2018 Q4 | 1.14 Billion CNY | 0.0% |
| 2018 Q2 | 916.11 Million CNY | 0.0% |
| 2018 FY | 2.05 Billion CNY | 9.68% |
| 2017 Q4 | 1.01 Billion CNY | 0.0% |
| 2017 FY | 1.87 Billion CNY | 22.5% |
| 2017 Q2 | 862.11 Million CNY | 0.0% |
| 2016 Q2 | 705.2 Million CNY | 0.0% |
| 2016 Q4 | 827.63 Million CNY | 0.0% |
| 2016 FY | 1.53 Billion CNY | 11.7% |
| 2015 Q2 | 602.26 Million CNY | 0.0% |
| 2015 FY | 1.37 Billion CNY | 13.76% |
| 2015 Q4 | 770 Million CNY | 0.0% |
| 2014 Q4 | 699.29 Million CNY | 0.0% |
| 2014 FY | 1.2 Billion CNY | 35.94% |
| 2014 Q2 | 506.96 Million CNY | 0.0% |
| 2013 FY | 887.35 Million CNY | 17.06% |
| 2013 Q4 | 467.66 Million CNY | 0.0% |
| 2013 Q2 | 419.69 Million CNY | 0.0% |
| 2012 Q1 | 189.5 Million CNY | 0.0% |
| 2012 Q3 | 189.5 Million CNY | 0.0% |
| 2012 FY | 758.03 Million CNY | 0.0% |
| 2012 Q4 | 221.83 Million CNY | 17.06% |
| 2012 Q2 | 189.5 Million CNY | 0.0% |
| 2011 Q4 | 189.5 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 554.58 Million HKD | -1722.547% |
| UMP Healthcare Holdings Limited | 748.48 Million HKD | -1250.387% |
| Human Health Holdings Limited | 590.81 Million HKD | -1610.761% |
| EuroEyes International Eye Clinic Limited | 714.28 Million HKD | -1315.043% |
| Kato (Hong Kong) Holdings Limited | 271.33 Million HKD | -3625.114% |
| Bamboos Health Care Holdings Limited | 94.78 Million HKD | -10563.382% |
| Beijing Health (Holdings) Limited | 140.34 Million HKD | -7101.844% |
| C-MER Eye Care Holdings Limited | 1.92 Billion HKD | -425.348% |
| Town Health International Medical Group Limited | 1.83 Billion HKD | -451.407% |
| Medicskin Holdings Limited | 49.13 Million HKD | -20470.876% |
| Hang Chi Holdings Limited | 211.21 Million HKD | -4685.431% |